Skip to content
JCP
PCC
News
CME
About
Authors & Reviewers
Sign In
Subscribe
Search
Advanced Search
Menu
JCP
PCC
News
CME
About
Authors & Reviewers
Sign In
Subscribe
Clinical Topics
View All
Addiction
Anxiety
Bipolar Disorder
Depression
Difficult to Treat Depression
Neurology
OCD
Psychopharmacology
PTSD and Trauma
Schizophrenia
Tardive Dyskinesia
View All
Collections
View All
Academic Highlights
Auvelity: Information from Industry
Banner Alzheimer’s Institute
Clinical & Practical Psychopharmacology
Early Career Psychiatrists
Focus on Childhood and Adolescent Mental Health
Focus on Geriatric Psychiatry
Focus on Psychotherapy
Focus on Suicide
Focus on Psychosis
Focus on Women’s Mental Health
Rounds in the General Hospital
Ibrahim Gunay, MD
PCC
Original Research
Long-Term Safety and Tolerability of Rivastigmine in Patients With Alzheimer's Disease Switched From Donepezil: An Open-Label Extension Study
October 15, 2008
Gary S. Figiel
,
Barbara Koumaras
,
Xiangyi Meng
, et al
PCC
Original Research
Safety and Efficacy of Rivastigmine in Patients With Alzheimer's Disease Not Responding Adequately to Donepezil: An Open-Label Study
August 15, 2008
Gary S. Figiel
,
Carl H. Sadowsky
,
John Strigas
, et al
PCC
Original Research
Adding Memantine to Rivastigmine Therapy in Patients With Mild-to-Moderate Alzheimer's Disease: Results of a 12-Week, Open-Label Pilot Study
October 16, 2006
Matthias W. Riepe
,
Georg Adler
,
Bernd Ibach
, et al
JCP
Original Research
Patterns of Concomitant Psychotropic Medication Use During a 2-Year Study Comparing Clozapine and Olanzapine for the Prevention of Suicidal Behavior
May 1, 2004
Ira D. Glick
,
Rocco Zaninelli
,
Chuanchieh Hsu
, et al
